Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antiretroviral combination therapy markedly reduces risk of heterosexual HIV-1 transmission.

Antiretroviral combination therapy markedly reduces risk of heterosexual HIV-1 transmission. Evid Based Med. 2012 Jun; 17(3):95-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.